NOV 12, 2020 6:00 AM PST

The Enzyme That Keeps Viruses In Stealth Mode

WRITTEN BY: Tara Fernandez

Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic infection if left untreated, leading to potentially life-threatening symptoms such as liver damage. In the case of such infections, why doesn’t the body’s immune system detect and eliminate such viruses?

Researchers at the University of Missouri School of Medicine have found another piece of the puzzle surrounding this question: an enzyme called sphingosine kinase 2, or SphK2, that allows viruses to remain in stealth mode, evading immune clearance. The findings, published in the Journal of Clinical Investigation, point to a promising therapeutic target to treat these persistent viral infections.

Senior author Bumsuk Hahm said, “There is very little research on how the sphingosine kinase 2 (SphK2) enzyme affects the immune responses to viral infections.” 

“We hypothesized that this enzyme suppresses the T cells that fight infections and allows viruses to persist.”

The scientists used a mouse model of lymphocytic choriomeningitis virus infection to test this theory, a common virus affecting rodents. After being administered a pharmaceutical agent to temporarily suppress SphK2, the mice launched a strong immune response that attacked and removed the virus.

“SphK2 is shown to regulate immune cell responses during a viral infection, and inhibition of this enzyme is effective in clearing a persistent viral infection,” said Hahm, who added,  “We believe targeting SphK2 may provide a promising route for developing a drug to elicit protective immunity against viral infections that have a devastating impact on human health.”

Excitingly, inhibiting SphK2 may not only work for getting rid of viruses, but also tumor cells. The study also demonstrated that targeting SphK2 restored the activity of cancer-killing T cells in the immunosuppressive tumor microenvironment.

 

 

Sources: JCI, Technology Networks.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
JUN 10, 2021
Immunology
Decoding the Immune System's Language
JUN 10, 2021
Decoding the Immune System's Language
Scientists at UCLA have decoded the “vocabulary” of immune cells—six distinct signals used as flares t ...
JUN 17, 2021
Immunology
How T Cells Sense Dangerous Invaders
JUN 17, 2021
How T Cells Sense Dangerous Invaders
T cells form a major part of our immune defenses, protecting us against the constant barrage of potentially pathogenic p ...
JUL 08, 2021
Cancer
Activating p53 May Boost Efficacy of Cancer Immunotherapy
JUL 08, 2021
Activating p53 May Boost Efficacy of Cancer Immunotherapy
Pharmacological activation of the p53 protein in cancer cells leads to an anti-tumor immune response in lab tests. These ...
AUG 24, 2021
Immunology
Women Produce More COVID Antibodies Than Men
AUG 24, 2021
Women Produce More COVID Antibodies Than Men
An exploration into the human immune response after a COVID-19 infection has revealed a surprising finding: women produc ...
SEP 14, 2021
Health & Medicine
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
SEP 14, 2021
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
As treatments and infection control practices surrounding COVID-19 continue to evolve, nanotechnological solutions are b ...
Loading Comments...